Related Experiment Videos
Enkephalin photoaffinity probes: synthesis and binding properties.
M Belcheva1, G Csanady, M Szucs
1Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, Szeged.
Neuropeptides
|October 1, 1988
Summary
New opioid receptor ligands were synthesized, showing reduced potency but acting as specific photoaffinity probes. Photolysis caused irreversible receptor loss, confirming their utility in studying opioid receptors.
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Pharmacology
Background:
- Enkephalins are endogenous opioid peptides involved in pain modulation and reward pathways.
- Opioid receptors are critical targets for pain management and addiction therapies.
- Photoaffinity labeling is a technique used to identify and characterize receptor-ligand interactions.
Purpose of the Study:
- To synthesize novel diazomethyl ketone derivatives of D-Ala2-Leu-enkephalin and Leu-enkephalin.
- To evaluate the binding affinities and functional activity of these novel compounds.
- To assess the potential of these compounds as photoaffinity probes for opioid receptors.
Main Methods:
- Chemical synthesis of diazomethyl ketone derivatives.
- Radioligand binding assays using [3H]naloxone and [3H]DALE.
- Photoaffinity labeling experiments involving photolysis of bound ligands to rat brain membranes.
Main Results:
- The synthesized diazomethyl ketone derivatives exhibited decreased potency compared to parent enkephalins.
- These new compounds displayed micromolar affinities for [3H]naloxone and [3H]DALE binding sites.
- Photolysis of bound ligands resulted in approximately 30% irreversible loss of opioid receptors.
- Opiate antagonist naloxone prevented photoinactivation, confirming ligand specificity.
Conclusions:
- Diazomethyl ketone derivatives of enkephalins can serve as specific photoaffinity probes for opioid receptors.
- These probes facilitate the study of opioid receptor structure and function through irreversible labeling.
- The findings contribute to the development of novel tools for opioid receptor research.